• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME MONITOR Back to Search Results
Model Number XS PST
Device Problem Non Reproducible Results (4029)
Patient Problems Stroke/CVA (1770); Fall (1848); Numbness (2415)
Event Date 10/01/2022
Event Type  Injury  
Manufacturer Narrative
The meter was requested for investigation.The test strips are not available for return.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: "coaguchek method uses human recombinant thromboplastin.Therefore, the comparability to tests using other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastin types.However, those higher differences between thromboplastins of different (rabbit, bovine) origin are not an issue specific for coaguchek assays.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared with several other (rabbit, bovine) laboratory methods".Initial reporter occupation: patient/consumer.
 
Event Description
We received an allegation that the coaguchek xs meter with serial number (b)(4) may have contributed to a patient's stroke.The reporter initially called because the meter result on (b)(6) 2023 was 4.9 inr and for assistance with ordering test strips.During the call, the reporter mentioned a stroke event in (b)(6) 2022.The exact date in (b)(6) was unknown to the reporter.The reporter alleged that there were error messages on the meter prior to the stroke and the patient was unable to use the meter.The reporter allegedly could not recall what error messages she received.The reporter alleged that in (b)(6) 2022, the patient felt weird and fell.It was reported that the patient's family had to call an ambulance.The reporter allegedly could not recall the inr result in the emergency room.The patient was allegedly admitted to the hospital where a computed tomography (cat) scan was performed and it was determined the patient had a stroke in her right brain.The physician reportedly stated that the stroke could have been caused by her blood pressure being so high when she arrived at the hospital.The patient allegedly did not injure herself from the fall and her left side was numb while in the hospital.The reporter allegedly believes that a cat scan was performed instead of a magnetic resonance imaging (mri) because the patient had a heart valve.The reporter could not recall any treatments that were done while the patient was in the hospital.The reporter alleged that the dates in the meter were all incorrect and that the patient does not keep a record for comparison.The reporter does not recall what the meter result was or if there were any warfarin dose adjustments made prior to the patient's stroke.The patient was reportedly sent to rehabilitation when she was discharged from the hospital.The meter memory was reviewed on the call.The reporter alleged a result of 2.0 inr was present in the meter memory with a date of (b)(6) 2022 at 6:24 am.Reportedly, prior to the stroke, the patient was testing as often as the physician required.It was also alleged that the patient was not always doing the correct procedure while testing.The therapeutic range is 2.0-3.0 inr.The interval of testing is every two weeks.The following additional information has been requested: - whether the stroke was hemorrhagic or ischemic.- any medications or treatment the patient received.- whether the patient tested by another method when they received error messages on the meter.This mdr is being submitted with an abundance of caution.The test strip lot number was requested but not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME MONITOR
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16559830
MDR Text Key311478551
Report Number1823260-2023-00847
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702125100
UDI-Public00365702125100
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 03/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberXS PST
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/14/2023
Initial Date FDA Received03/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMLODIPINE.; ASA.; ATORVASTATIN.; BACTRIM.; CARVEDILOL.; HYDRALAZINE.; SILDENAFIL.; TARVISINE.; WARFARIN.
Patient Outcome(s) Other; Hospitalization;
Patient Age55 YR
Patient SexFemale
Patient Weight91 KG
-
-